Bank of America's list is based on the stocks’ relative-performance sensitivity to changes in the 10-year Treasury yield.

Needham analyst Mike Matson, who has a buy rating and $229 price target on ResMed, says the company will be helped by a Royal Philips recall.

The market needs clarity on the vaccine and the election.

Stock futures fall as Wall Street braces for the U.S. jobs report for March and coronavirus infections across the globe surpass 1 million; Tesla delivers its 'best ever' first-quarter performance; American Airlines drastically reduces both domestic and international flights.

Investors can’t fight this kind of selling, but they shouldn’t give up. Jim Cramer’s got a case for sitting tight. It will end.

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.